Medication info
Dual-X Tablet 5/160mg

Dual-X Tablet 5/160mg

Prescription medicationTabletOral
Ingredient · strength
Valsartan›160mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tablet
Manufacturer / importer
Mothers Pharmaceutical Co., Ltd.
Appearance
Dark yellow oval film-coated tablet
Packaging
28 tablets/PV[(14 tablets/PTPX2)]
Approval status
Active

MFDS item code 201706744 · Approved 2017.08.22 · Insurance code 622802990

Summary

Main use
Treatment of essential hypertension not adequately controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water regardless of food. It is recommended to take it at the same time each day, if possible (e.g., in the morning). Before administering this drug, it is recommended to adjust the dose using the individual components (amlodipine or valsartan); however, if blood pressure is not adequately controlled with monotherapy using the individual components, switching directly to this drug may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 10mL/min or greater); however, this drug should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this drug to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years and older: Use caution when increasing the dose.
Child dose
Use of this drug is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.

Ingredients

Manufacturer
Mothers Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not adequately controlled with monotherapy

  • Essential hypertension
View approved original text

Essential hypertension is a condition where blood pressure consistently exceeds the normal range, and in some cases, blood pressure may not be adequately controlled with either amlodipine or valsartan monotherapy. In such cases, additional treatment or combination with other medications may be considered. Since essential hypertension increases the risk of stroke, heart disease, and other complications, appropriate treatment is very important. Amlodipine works by dilating blood vessels to lower blood pressure, while valsartan helps control blood pressure by inhibiting vascular contraction. By effectively managing blood pressure using these medications, the risk of complications due to hypertension can be reduced. Therefore, these medications are used for the control of essential hypertension.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water regardless of food. It is recommended to take it at the same time each day, if possible (e.g., in the morning). Before administering this drug, it is recommended to adjust the dose using the individual components (amlodipine or valsartan); however, if blood pressure is not adequately controlled with monotherapy using the individual components, switching directly to this drug may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 10mL/min or greater); however, this drug should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this drug to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years and older: Use caution when increasing the dose.

Child dose

Use of this drug is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, particularly in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. It should not be administered to individuals with hypersensitivity to the drug, pregnant or nursing women, patients with severe renal or hepatic impairment, or those with certain heart diseases. Patients with depletion of fluids or sodium, hyperkalemia, renal artery stenosis, etc., should have their blood pressure and renal function closely monitored while using this medication. Side effects such as dizziness, headache, swelling, and lowered blood pressure may occur when taking this medication. If severe allergic reactions or angioedema occur, the medication should be stopped immediately. Caution is needed as dizziness or fatigue may occur while driving or operating machinery. This medication may interact with other antihypertensive drugs, potassium supplements, diuretics, non-steroidal anti-inflammatory drugs, etc., so it is important to consult with a doctor or pharmacist if you are taking any other medications. Women who are pregnant or planning to become pregnant should not use this medication, and nursing mothers are also advised against its use. This medication is not recommended for patients under 18 years of age due to insufficient safety and efficacy data. Symptoms such as hypotension, dizziness, and tachycardia may occur with overdose; therefore, the prescribed dosage must be strictly followed, and if unusual symptoms occur, medical consultation is required.

Side effects

Pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pain in the pharynx and larynx, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, sweating, rash, itching, joint swelling, low back pain, arthritis, muscle spasms, lethargy, polyuria, nocturia, erectile dysfunction, edema, peripheral edema, facial edema, peripheral edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infections, viral infections, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremor, sensory decrease, taste disturbance, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorder, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, throat pain, hypercholesterolemia, hypoglycemia, nervous hyperreactivity, Stevens-Johnson syndrome, itching, peripheral edema, hypotension, edema, chest pain, pain, cough, nocturnal enuresis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. The optimal storage temperature is between 1°C and 30°C at room temperature. Proper storage will help maintain the medication's effectiveness over time.

Appearance and packaging

Appearance

Dark yellow oval film-coated tablet

Package unit

28 tablets/PV[(14 tablets/PTPX2)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.